Patents Assigned to The University of Miami
-
Patent number: 9217696Abstract: Improved methods and systems for processing of solid tissue are described. The method may be performed manually or automatically. The system may have modules such as (i) a grossing module where a fresh tissue is sliced to prepare a tissue specimen, (ii) a hardening module that hardens the tissue specimen, (iii) an impregnating module that impregnates the tissue specimen that was hardened, and (iv) an embedding module that embeds a tissue specimen that was hardened and impregnated. Fresh (i.e., not fixed or frozen) tissue, which was excised to diagnose disease or to assess surgical treatment, is grossed to about 0.6 mm. Preferably, the hardening of fresh tissue is initiated, but not completed, during grossing by contact with a chemical admixture. Preferably, dry ice, a thermoelectric device, or a gas condenser cools a metal mold containing the embedded specimen.Type: GrantFiled: September 28, 2012Date of Patent: December 22, 2015Assignee: The University of MiamiInventor: Azorides Morales
-
Patent number: 9079974Abstract: There are provided a novel series of peptide analogs of hGH-RH(1-29)NH2 and hGH-RH(1-30)NH2 which show high activities in stimulating the release of pituitary GH in animals. They retain their physiological activity in solution for extended periods of time and resist enzymic degradation in the body. These novel and useful properties appear to be due to novel substitution patterns ant at the 1, 15, 27 and 29 positions on the peptide.Type: GrantFiled: December 21, 2011Date of Patent: July 14, 2015Assignees: The University of Miami, The United States of America, represented by the Department of Veterans AffairsInventors: Andrew V Schally, Ren Zhi Cai, Marta Zarandi
-
Patent number: 8475785Abstract: Cell-based immunotherapy (e.g., immunization or vaccination) may be improved by frequent administration to a human subject of allogeneic cancer cells secreting a modified heat shock protein (e.g., gp96), depletion of B cells in the subject, or both. Antigen (e.g., epitope derived from neoantigen or tumor antigen of allogeneic or syngeneic cancer cells) may induce a specific immune response in the subject. For example, the epitope bound in an immunogenic complex with the secreted heat shock protein may be obtained from allogeneic cancer cells coexpressing both secreted gp96 and antigen, or from syngeneic cancer cells of the subject expressing only antigen.Type: GrantFiled: March 3, 2009Date of Patent: July 2, 2013Assignee: The University of MiamiInventors: Eckhard R. Podack, Joseph D. Rosenblatt, Nozomi Yamazaki
-
Patent number: 8304537Abstract: Heterocyclic compounds incorporating a [1,3]oxazine ring may be used to make chromogenic materials. These molecules switch from a colorless state to a colored form upon addition of either acid or base. In both instances, the [1,3]oxazine ring opens in response to the pH change forming an indolium cation, after the addition of acid, or a phenolate anion, after the addition of base. Alternatively, the switch may occur in response to a change in electrical current or potential or a change in temperature. Chromophores absorb in the visible region of the electromagnetic spectrum. Hence, their formation translates into the appearance of color. These processes are fully reversible and the original colorless state can be regenerated by switching the pH back to neutral. Thus, these halochromic compounds can be used to develop displays, filters, indicators, lenses, sensors, switches, or windows able to switch their color in response to pH changes.Type: GrantFiled: October 17, 2008Date of Patent: November 6, 2012Assignee: The University of MiamiInventors: Massimiliano Tomasulo, Francisco M. Raymo
-
Patent number: 8288168Abstract: Improved systems and methods for tissue processing are described here. The chemical process and the construction of the apparatus are simplified by using only two different solutions in two separate reaction modules. They are compatible with processing of tissue specimens for genetic analysis, histology, in situ antibody binding and hybridization, archival preservation of morphology and nucleic acids, and combinations thereof.Type: GrantFiled: November 20, 2008Date of Patent: October 16, 2012Assignee: The University of MiamiInventor: Azorides R. Morales
-
Patent number: 8252209Abstract: We have designed a molecular switch based on the photoinduced opening and thermal closing of a [1,3]oxazine ring. A substituted [1,3]oxazine compound described as having a general (i.e., unsubstituted) structure with fused indoline and benzooxazine fragments such that they share a common bond in the [1,3]oxazine compound: (i) the bond connecting positions 1 and 2 of the indoline fragment and (ii) the bond connecting positions 2 and 3 of the benzooxazine fragment. Irradiation by light of suitable wavelength and intensity of this photochromic compound induces cleavage of a [C—O] bond of the [1,3]oxazine ring to form a phenolate chromophore. The photogenerated (e.g., colored) isomer may revert thermally to the starting (e.g., colorless) oxazine. Alternatively, the switch may be between isomers of the compound that absorb at different wavelengths. Reversible coloration of silica or polymeric materials and switching optical signals may involve many cycles of interconversion between different colored states.Type: GrantFiled: August 6, 2010Date of Patent: August 28, 2012Assignee: The University of MiamiInventors: Francisco M. Raymo, Massimiliano Tomasulo
-
Patent number: 8221996Abstract: A process and apparatus for rapid, continuous flow histological processing of tissues is disclosed. The steps of fixation, dehydration, clearing and impregnation are performed in less than one hour; this allows a pathologist to evaluate samples shortly after receipt, perhaps while the patient is still in the operating room. Rapid and continuous processing is accomplished by decreasing the thickness of tissue sections, use of non-aqueous solutions composed of admixtures of solutions, solution exchange at elevated temperature and with agitation, and impregnation under vacuum pressure. The patient in surgery is thus provided with point-of-care surgical pathology.Type: GrantFiled: March 12, 2008Date of Patent: July 17, 2012Assignee: The University of MiamiInventors: Azorides Morales, Harold Essenfeld, Ervin Essenfeld
-
Patent number: 8198436Abstract: A chromogenic oxazine compound for the colorimetric detection of cyanide was designed. Indeed, the [1,3]oxazine ring of our compound opens to form a phenolate chromophore in response to cyanide. The heterocyclic com-pound may be comprised of fused benzooxazine and indoline rings: wherein R1 is an alkyl (e.g., methyl, ethyl, propyl, isopropyl, butyl, isobutyl), a substituted alkyl, a cycloalkyl (e.g., cyclopentyl, cyclohexyl), a substituted cycloalkyl, an aryl (e.g., phenyl), or a substituted aryl and R2 is a chromophore (e.g., nitroso, nitro, azo dyes). This quantitative chromogenic transformation permits the detection of micromolar concentrations of cyanide in water. Furthermore, our chromogenic oxazine is insensitive to the presence of large concentrations of fluoride, chloride, bromide or iodide anions, which are generally the principal interferents in the colorimetric detection of cyanide.Type: GrantFiled: September 1, 2006Date of Patent: June 12, 2012Assignee: The University of MiamiInventors: Francisco M. Raymo, Massimiliano Tomasulo
-
Patent number: 8198099Abstract: Semiconductor quantum dots are becoming valuable analytical tools for use in biomedical applications. Indeed, their unique properties offer the opportunity to design luminescent probes for imaging and sensing with unprecedented performance. In this context, we have identified operating principles to transduce supramolecular association of complementary receptor-ligand binding pairs into enhancement or suppression in the luminescence of sensitive quantum dots. Thus, complementary receptor-ligand binding pairs can be identified with luminescence measurements relying on our design logic. In fact, we have demonstrated with a representative example that our protocol can be adapted to signal receptor-ligand binding.Type: GrantFiled: July 9, 2007Date of Patent: June 12, 2012Assignee: The University of MiamiInventors: Francisco M. Raymo, Massimilliano Tomasulo, Ibrahim Yildiz
-
Patent number: 8097033Abstract: A prosthetic device and method to restore extraocular muscle function. The device includes a housing; a biasing component disposed in the housing; a proximal connector operatively connected to a proximal end of the biasing component; and a distal connector operatively connected to a distal end of the biasing component, wherein the proximal connector is configured for being secured with respect to an orbital bone and the distal connector adapted to be secured to the paralyzed or absent muscle stump, e.g. on the globe, or to the eyelid.Type: GrantFiled: June 13, 2006Date of Patent: January 17, 2012Assignee: The University of MiamiInventor: David T. Tse
-
Patent number: 8053241Abstract: A novel reagent is used to identify arsenic-treated wood. The stain may detect arsenic extracted from wood into solution; arsenic transferred from wood to a wipe, which is then extracted into solution; or the stain may be directly applied at a predetermined location on the wood's surface. Copper preservatives are not detected by the stain and phosphate interference is minimized. The process is quick, inexpensive, and easy to use. Development of a blue color (i.e., reduction of at least some Mo (VI) to Mo (V) in molybdenum blue) indicates the presence of arsenic.Type: GrantFiled: October 24, 2006Date of Patent: November 8, 2011Assignee: The University of MiamiInventors: Helena M. Solo-Gabriele, Amy L. Omae, Timothy G. Townsend
-
Publication number: 20110039805Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.Type: ApplicationFiled: July 21, 2010Publication date: February 17, 2011Applicant: The University of MiamiInventors: Stephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer
-
Patent number: 7807458Abstract: Described herein are post natal, multilineage inducible cells (MIAMI cells). In some examples, the cells are isolated from non fractionated, adult (males and females 3 to 72 years old) human bone marrow under cell culture conditions, which are believed to resemble an in vivo niche microenvironment in which primitive multipotent cells exist. MIAMI cells have a unique profile of molecular markers, and can be maintained in vitro (for more than 50 population doublings) without detectable changes in their characteristic molecular profile. MIAMI cells can be differentiated into mesodermal, neuroectodermal, and endodermal cell lineages. Methods of isolating, differentiating and using MIAMI cells are also described.Type: GrantFiled: January 29, 2004Date of Patent: October 5, 2010Assignees: The United States of America as represented by the Secretary of the Department of Veterans Affairs, The University of MiamiInventors: Paul C. Schiller, Gianluca D'Ippolito
-
Patent number: 7790437Abstract: An organ transportation device includes a fluid-tight organ container and structure within the organ container for engaging an organ within the organ container. A base assembly is provided, and structure for rotating the organ engaging structure and the organ relative to the base assembly. The base assembly can have a motor and a battery to provide for rotation of the organ container during shipping.Type: GrantFiled: December 14, 2006Date of Patent: September 7, 2010Assignees: Biorep Technologies, Inc., The University of MiamiInventors: Ramon E. Poo, Camillo Ricordi
-
Patent number: 7790068Abstract: We have designed a molecular switch based on the photoinduced opening and thermal closing of a [1,3]oxazine ring. A substituted [1,3]oxazine compound described as having a general (i.e., unsubstituted) structure with fused indoline and benzooxazine fragments such that they share a common bond in the [1,3]oxazine compound: (i) the bond connecting positions 1 and 2 of the indoline fragment and (ii) the bond connecting positions 2 and 3 of the benzooxazine fragment. Irradiation by light of suitable wavelength and intensity of this photochromic compound induces cleavage of a [C—O] bond of the [1,3]oxazine ring to form a phenolate chromophore. The photogenerated (e.g., colored) isomer may revert thermally to the starting (e.g., colorless) oxazine. Alternatively, the switch may be between isomers of the compound that absorb at different wavelengths. Reversible coloration of silica or polymeric materials and switching optical signals may involve many cycles of interconversion between different colored states.Type: GrantFiled: February 20, 2007Date of Patent: September 7, 2010Assignee: The University of MiamiInventors: Francisco M. Raymo, Massimiliano Tomasulo
-
Patent number: 7758641Abstract: A prosthetic device and method to restore extraocular muscle function. The device includes a housing; a biasing component disposed in the housing; a proximal connector operatively connected to a proximal end of the biasing component; and a distal connector operatively connected to a distal end of the biasing component, wherein the proximal connector is configured for being secured with respect to an orbital bone and the distal connector adapted to be secured to the paralyzed or absent muscle stump, e.g. on the globe, or to the eyelid.Type: GrantFiled: March 18, 2009Date of Patent: July 20, 2010Assignee: The University of MiamiInventor: David T. Tse
-
Publication number: 20090182420Abstract: A prosthetic device and method to restore extraocular muscle function. The device includes a housing; a biasing component disposed in the housing; a proximal connector operatively connected to a proximal end of the biasing component; and a distal connector operatively connected to a distal end of the biasing component, wherein the proximal connector is configured for being secured with respect to an orbital bone and the distal connector adapted to be secured to the paralyzed or absent muscle stump, e.g. on the globe, or to the eyelid.Type: ApplicationFiled: March 18, 2009Publication date: July 16, 2009Applicant: The University of MiamiInventor: David T. Tse
-
Patent number: 7547538Abstract: A process and apparatus for rapid, continuous flow histological processing of tissues is disclosed. The steps of fixation, dehydration, clearing and impregnation are performed in less than one hour; this allows a pathologist to evaluate samples shortly after receipt, perhaps while the patient is still in the operating room. Rapid and continuous processing is accomplished by decreasing the thickness of tissue sections, use of nonaqueous solutions composed of admixtures of solutions, solution exchange at elevated temperature and with agitation, and impregnation under vacuum pressure. The patient in surgery is thus provided with point-of-care surgical pathology.Type: GrantFiled: March 27, 2003Date of Patent: June 16, 2009Assignee: The University of MiamiInventors: Azorides Morales, Harold Essenfeld, Ervin Essenfeld
-
Publication number: 20090136992Abstract: Improved systems and methods for tissue processing are described here. The chemical process and the construction of the apparatus are simplified by using only two different solutions in two separate reaction modules. They are compatible with processing of tissue specimens for genetic analysis, histology, in situ antibody binding and hybridization, archival preservation of morphology and nucleic acids, and combinations thereof.Type: ApplicationFiled: November 20, 2008Publication date: May 28, 2009Applicant: The University of MiamiInventor: Azorides R. MORALES
-
Patent number: 7526987Abstract: A tool for holding tissue to be sampled in place to allow tissue samples of a prescribed thickness to be prepared from the held tissue. The tool includes at least one tine array for engaging and holding the tissue. First and second tine arrays may advantageously be provided to define a slice thickness therebetween. In addition, or in the alternative, the tines of the tine array are mutually spaced apart by different distances to effectively hold the tissue and to define prescribed tissue sample lengths.Type: GrantFiled: April 12, 2007Date of Patent: May 5, 2009Assignee: The University of MiamiInventor: Azorides R. Morales